Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 104.95 M106.48 M108.69 M103.27 M 423.39 M Research & development ———— — Operating income 36.2 M48.84 M43.47 M37.64 M 166.15 M Non-Operating Income, Total 612 K5.16 M2.12 M-605 K 7.29 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 612 K5.16 M2.12 M-605 K 7.29 M Unusual income/expense ———— — Pretax income 36.81 M54 M45.59 M37.04 M 173.44 M Equity in earnings ———— — Taxes 9.68 M15.84 M12.19 M11.61 M 49.32 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 27.13 M38.16 M33.4 M25.43 M 124.12 M Discontinued operations 10.57 M-3.31 M1.65 M-400 K 8.52 M Net income 37.7 M34.85 M35.05 M25.03 M 132.64 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 37.7 M34.85 M35.05 M25.03 M 132.64 M Basic earnings per share (Basic EPS) 1.431.321.340.96 5.05 Diluted earnings per share (Diluted EPS) 1.431.321.330.95 5.03 Average basic shares outstanding 26.27 M26.36 M26.17 M26.23 M — Diluted shares outstanding 26.38 M26.41 M26.29 M26.37 M — EBITDA 155.63 M169.24 M165.32 M44.18 M 534.37 M EBIT 148.22 M162.12 M158.65 M37.76 M 506.75 M Cost of revenue 489.69 M446.3 M456.52 M434.44 M 1.83 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 7.41 M7.11 M6.67 M6.42 M 27.61 M